PR PolyResearch
Join Free
NASDAQ

Translational Development Acquisition Corp. - Ordinary Shares (TDAC)

♥ 372 Thanks from members

Translational Development Acquisition Corp. (TDAC) demonstrates strong investor backing, evidenced by a successful shareholder vote and a low 15% redemption rate following its proposed business combination agreement with lithium ceramic battery leader ProLogium Holding Inc.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →

Other Nasdaq Tickers

NASDAQ
GraniteShares 2x Long AAPL Daily ETF (AAPB)
NASDAQ
Apple Inc. (AAPL)
NASDAQ
Direxion Daily AAPL Bear 1X ETF (AAPD)
NASDAQ
Ascentage Pharma Group International - American Depository Shares (AAPG)
NASDAQ
Direxion Daily AAPL Bull 2X ETF (AAPU)
NASDAQ
Rocket Pharmaceuticals, Inc. - Warrant (RCKTW)